Seeing Is Believing
Currently out of the existing stock ratings of Travis Steed, 19 are a HOLD (25.33%), 50 are a BUY (66.67%), 6 are a SELL (8%).
Analyst Travis Steed works at BAML with a stock forecast success ratio of 49.42% fulfilled within 146.65 days on average.
Travis Steed’s has documented 147 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EW, Edwards Lifesciences Corp at 07-Mar-2024.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 8/24/2018. The price target of $45 was fulfilled within 7 days with a profit of $6.63 (17.28%) receiving and performance score of 24.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
125
$14.48 (13.10%)
114
16 days ago
4/5 (80%)
$14.89 (13.52%)
388
Buy
141
$30.48 (27.58%)
133
2 months 25 days ago
13/21 (61.9%)
$28.99 (25.88%)
291
Buy
126
$15.48 (14.01%)
130
2 months 26 days ago
7/14 (50%)
$13.55 (12.05%)
292
Buy
127
$16.48 (14.91%)
110
2 months 26 days ago
12/18 (66.67%)
$14.55 (12.94%)
190
Buy
125
$14.48 (13.10%)
125
2 months 27 days ago
6/7 (85.71%)
$14.23 (12.85%)
250
Which stock is Travis Steed is most bullish on?
Which stock is Travis Steed is most reserved on?
What Year was the first public recommendation made by Travis Steed?